A new study by researchers at the University of Strathclyde, UK, is set to investigate a new method of enhancing brain activity for the prevention of Alzheimer’s disease.

The 14-month study aims to evaluate the use of light stimulation to block the build-up of a toxic protein, beta-amyloid, in the cells of the brain areas that are vulnerable to the disease.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Sponsored by Alzheimer’s Research UK, the study is intended to provide a new prevention strategy for people who are at high risk of the disease.

Study lead researcher and Strathclyde Institute of Pharmacy and Biomedical Sciences senior lecturer Dr Shuzo Sakata said: “The lack of a cure for Alzheimer’s disease means there is an urgent need to develop new, innovative approaches to combating it.

“The lack of a cure for Alzheimer’s disease means there is an urgent need to develop new, innovative approaches to combating it.”

“We have known for a long time that the beta-amyloid protein is toxic to brain cells; it has recently been found that manipulating the activity of neurons can reduce the protein in some regions of the brain.

“But what is not well understood is how it can be used to do this across many brain regions at the same time.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Initially, the team will carry out a pre-clinical research on a brain area that communicates with various other areas and is commonly affected by the disease.

The researchers will assess the impact of using light to activate neurons in this particular area for enhancing fast brainwaves impaired in Alzheimer’s patients.

Furthermore, the study aims to determine if the build-up of the beta-amyloid protein in different areas of the brain could be minimised by the enhancement of brainwaves.